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OBJECTIVE: Noonan syndrome is a multiple congenital anomaly syndrome, and bleeding diathesis is considered
part of the clinical findings. The purpose of this study was to determine the frequency of hemostatic abnormalities in a group
of Noonan syndrome patients.
METHOD: We studied 30 patients with clinical diagnosis of Noonan syndrome regarding their hemostatic status
consisting of bleeding time, prothrombin time, activated partial thromboplastin time and thrombin time tests, a platelet
count, and a quantitative determination of factor XI.
RESULTS: An abnormal laboratory result was observed in 9 patients (30%). Although coagulation-factor deficiencies,
especially factor XI deficiency, were the most common hematological findings, we also observed abnormalities of platelet
count and function in our screening.
CONCLUSIONS: Hemostatic abnormalities are found with some frequency in Noonan syndrome patients (30% in our
sample). Therefore, we emphasize the importance of a more extensive hematological investigation in these patients, especially
prior to an invasive procedure, which is required with some frequency in this disorder.
DESCRIPTORS: Noonan syndrome. Hematological findings. Coagulation-factor XI deficiency.
INTRODUCTION
Noonan syndrome (NS) is an auto-
somal dominant disorder comprising
short stature, distinct craniofacial fea-
tures, short or webbed neck, congeni-
tal heart disease, cryptorchidism in
males, skeletal anomalies, and bleed-
ing diathesis1.
The gene for NS was recently iden-
tified (PTPN11) in the long arm of
chromosome 12. In a study of 22 pa-
tients affected by NS, 50% of them had
a mutation in this specific gene, in-
dicative of genetic heterogeneity in
the disorder2.
Hematological findings in NS have
been described as early as the first re-
ports of this condition, some of them
with a life-threatening hemorrhage.
Noonan (1968)3 described an affected
woman who had persistent thrombocy-
topenia. Several other descriptions of
abnormal platelet count4,5 and func-
tion6 in this disorder followed. Defi-
ciency of coagulation factors, espe-
cially factor XI7, is also considered part
of the syndrome. Moreover, the asso-
ciation of myeloproliferative disorder,
mainly chronic myelomonocytic
leukemia in childhood, and NS was
not considered fortuitous8. The preva-
lence of reported hemostatic abnor-
malities in NS varies widely, ranging
from 20%9 to as high as 74%10. A
study with a large cohort of 72 patients
with NS by Sharland et al.11 found a
frequency of bleeding diathesis in
50%. Another study12 found similar re-
sults (56%) in an evaluation of 18 pa-
tients. The most common abnormality
in both studies was a factor XI defi-
ciency.
Since NS has a variety of condi-
tions that require surgical intervention,
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a previous knowledge of the hemos-
tatic status of these patients is essen-
tial for a better management of them.
We therefore screened 30 patients
with a clinical diagnosis of NS for
hemostatic abnormalities.
METHODS
Patients with a possible diagnosis
of NS were selected from our clinic.
Twenty-six of these probands fulfilled
the clinical criteria described by van
der Burgt et al.13 and were included in
this study. Their first-degree relatives
were also examined for a possible di-
agnosis of NS, and 5 of them were con-
sidered affected by this disorder. One
of these relatives had died prior to this
study, resulting in a total of 30 partici-
pant individuals. All the participating
patients underwent a standardized
questionnaire, including a detailed
history of tendency to bleed, a com-
plete physical examination, and a car-
diac work-up, comprising an EKG and
echocardiogram. A chromosome analy-
sis was performed in all probands.
The hematological study consisted
of a bleeding time (BT) test using the Ivy
method, a prothrombin time (PT) test, an
activated partial thromboplastin time
(APTT) test, a thrombin time (TT) test, a
platelet count, and a quantitative deter-
mination of factor XI. If any of these tests
yielded abnormal results, it was followed
by a more extensive work-up. Ingestion
of medications that could interfere in the
accuracy of the BT was avoided 2 weeks
prior to the tests.
In this study, the normal values for
the hematological tests are as follows:
BT: up to 7 minutes in children until
10 years of age and 10 minutes above
that age;
Platelet count: 150000-400000/mm3 ;
PT (R): 1-1.20 (patient PT/pool of
controls PT);
APTT (R): 0.76-1.16 (patient APTT/
pool of controls APTT);
Coagulation factors VIIIC and IX:
60%-160%;
Coagulation factors XI, XII, and
ristocetin cofactor: 50%-150%;
Von Willebrand factor: 60%-150%.
The patients were included in this
study only after a written consent form
was obtained.
RESULTS
Thirty patients (17 males and 13
females) were included in this study.
Ages ranged form 3 months to 41 years
(mean 12 years and 4 months). Twelve
probands (46%) were white, 10 were
mulatto (38%), 3 were black (12%),
and 1 was oriental (4%).
The main clinical findings of the
affected NS patients are summarized in
Table 1.
The most frequent cardiac anomaly
observed in this group of patients was
pulmonary stenosis (14 individuals),
followed by hypertrophic cardiomy-
opathy in 3 patients. One individual
had aortic stenosis, and another one
had ventricular septal defect (VSD).
All probands had a normal karyo-
type.
Nine patients (30%) reported a ten-
dency to bleed, characterized by easy
bruising, mild nose bleeding, and pro-
longed local bleeding after a simple
cut and dental extraction. A surgical
procedure had been performed in 15
patients (50%); some of them had
more than one surgical procedure.
These included primarily heart surgery
and/or cardiac catheterization (6 pa-
tients), an orchidopexia (5) and an
ENT surgery - tonsillectomy (3). The
other surgical procedures included a
herniorraphy and correction of the pto-
sis of the palpebral fissures and a
craniectomy in one patient due to an
ophthalmic artery aneurysm. Only 2 of
the patients who had an open-heart
surgery bled profusely, requiring
blood transfusion. In one of them, the
bleeding was attributed more to the
procedure itself, since re-operation
stopped the bleeding. In the other pa-
tient, we could not recover details of
the procedure.
An abnormal hemostatic profile
was obtained in 9 patients (30%) (Ta-
ble 2). Coagulation-factor deficiencies
were observed in 5 individuals (iso-
lated factor XI deficiency in 1 patient
and combined in another 2; isolated
factor XII deficiency in 1 patient and
combined in another patient, and fac-
tor VIII deficiency in 1 patient). One
individual with a combined deficiency
of factor XII and IX also had a platelet
aggregation defect. Isolated low plate-
let count and an increasing BT were
also found.
DISCUSSION
NS is a well recognized genetic
disorder, and although its incidence is
not accurately known, it is estimated
at 1/1000 to 1/250014, making this dis-
order one of the most common syn-
dromes associated with congenital
heart disease.
Due to its broad phenotypic spec-
trum, NS caught the attention of dif-
ferent clinicians. Studies in these pa-
tients have been performed in attempt
to better understand this heterogene-
ous disorder.
Table 1 - Clinical findings in 30
patients with Noonan syndrome.
CLINICAL FINDINGS Nº (%)
Short stature 21/30 (70%)
Hypertelorism 16/30 (53%)
Ptosis 15/30 (50%)
Downslanting of the 14/30 (47%)
palpebral fissures
High arched palate 13/30 (43%)
Dental malocclusion 11/30 (37%)
Short or webbed neck 26/30 (87%)
Cardiac anomaly 19/30 (64%)
Cryptorchidism 7/171  (41%)
(1) Number of affected males
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Several reports have emphasized
the importance of the hematological
aspects in NS, which include abnormal
platelet count and function, as well as
deficiency of various coagulation fac-
tors.
A bleeding diathesis has been con-
sidered part of NS, but its prevalence
varies widely. The largest study11 esti-
mated its frequency in 50%. In our
study, an abnormal laboratory screen
was observed in 30% of our patients,
which is a significant finding.
The most frequent hematological
abnormality described in NS is a fac-
tor XI deficiency11. It is interesting to
note that congenital deficiency of fac-
tor XI was described originally in per-
sons of Jewish ethnicity, where the ho-
mozygous state could present a severe
form of the disease7. In our study, fac-
tor XI deficiency was also the most
common hematological finding (33%),
and none of our patients were of Jew-
ish ethnicity. The background of the
patients studied had been emphasized
in other papers, prompting the conclu-
sion that there is an association be-
tween this hematological abnormality
and NS.
It is known that there is a poor cor-
relation between the tendency to
bleed and the level of circulating fac-
tor XI12. In our study, only 1 patient
who showed a mild deficiency of fac-
tor XI (41%), reported prolonged
bleeding after a dental extraction, but
had normal clotting in 2 surgical pro-
cedures (correction of his heart defect
and cryptorchidism). The other 2 pa-
tients denied any bleeding tendency.
One of them had a cardiac catheteri-
zation, and the other had correction of
the cryptorchidism and palpebral pto-
sis without bleeding problems. Both
also had a mild deficiency of factor XI
(37% and 40%).
The factor XII deficiency (31% and
32%), observed in 2 of our patients,
did not lead to a bleeding problem, as
expected. One of these patients, who
complained only of easy bruising, also
had a factor IX (49%) deficiency, as
well as a platelet function abnormal-
ity (hypoaggregation to ADP and
adrenalin). He underwent a correction
of an umbilical hernia without abnor-
mal bleeding.
Another patient, who also com-
plained of easy bruising, had a pro-
longed bleeding time and a platelet
hypoaggregation to ristocetin. The rest
of the tests were repeatedly normal,
and a diagnosis of von Willebrand dis-
ease could not be established.
The multiplicity of unrelated
types of bleeding abnormalities and
the variability of their expression in
NS are difficult to attribute to a single
gene defect15. It is possible that the
gene responsible for NS somehow in-
teracts with the regulation of other
genes involved in the coagulation
pathway. This could explain the great
variety of the hematological abnor-
malities seen in this disorder.
Although the hematological find-
ings in NS are complex and the corre-
lation between the clinical findings
and the circulating levels of some co-
agulation factors is not always precise,
all clinicians should be aware of this
problem and be prompted to conduct
a more extensive hematological work-
up in these patients. Prior knowledge
of a hemostatic abnormality in case of
an invasive procedure could be assur-
ing of a better management if bleed-
ing occurs.
Table 2 - Hematological findings in 30 patients with Noonan syndrome.
HEMATOLOGICAL FINDINGS Nº (%) BLEEDING TENDENCY SURGICAL PROCEDURE
Low platelet count 1/30 (3%) - -
Increased BT 1/30 (3%) Easy bruising -
Increased APTT 1/30 (3%) Easy bruising -
Isolated factor XI deficiency 1/30 (3%) - Cardiac catheterization
Combined factor XI deficiency 2/30 (7%) P1. Prolonged bleeding P1.Cardiac surgery and
(VIII, IX, and ristocetin cofactor) (dental extraction) cryptorchidism
P2. Cryptorchidism and ptosis
Isolated factor XII deficiency 1/30 (3%) - Pyloric hypertrophy
Combined factor XII deficiency (IX) 1/30 (3%) - Umbilical hernia
and deficient platelet aggregation
w/ increased BT
Isolated factor VIII deficiency 1/30 (3%) - -
TOTAL 9/30 (30%)
P1: patient 1; P2: patient 2
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RESUMO
to aos aspectos hematológicos que
consistiu de tempo de sangramento,
tempo de protrombina, tempo de
tromboplastina parcial ativada, tempo
de trombina, contagem de plaquetas e
dosagem do fator de coagulação XI.
RESULTADOS: Um resultado la-
boratorial anormal foi observado em 9
desses pacientes (30%). Apesar dos
achados mais comuns terem sido as
deficiências dos fatores de coagulação,
especialmente do fator XI, também ob-
servamos anormalidades no número e
na função plaquetária.
CONCLUSÕES: Anormalidades
BERTOLA DR e col. - Achados hema-
tológicos na síndrome de Noonan.
Rev. Hosp. Clín. Fac. Med. S. Pau-
lo 58(1):5-8, 2003.
OBJETIVO: A síndrome de
Noonan é uma patologia de múltiplas
anomalias congênitas e, dentre os
achados clínicos, a diátese hemor-
rágica está incluída. O propósito des-
te estudo é determinar a freqüência de
anormalidades hemostáticas nos paci-
entes afetados.
MÉTODO: Nós estudamos 30 pa-
cientes afetados pela síndrome quan-
hemostáticas são observadas com cer-
ta freqüência em pacientes com sín-
drome de Noonan (30% em nossa
amostra). Enfatizamos, portanto, a im-
portância de uma investigação hema-
tológica mais detalhada nesses pacien-
tes, especialmente antes da realização
de um procedimento invasivo, o qual
é requerido com certa freqüência na
síndrome.
DESCRITORES: Síndrome de
Noonan. Achados hematológicos. De-
ficiência do fator XI de coagulação.
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